Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.

Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group.

Mult Scler Relat Disord. 2019 Oct 4;36:101430. doi: 10.1016/j.msard.2019.101430. [Epub ahead of print]

PMID:
31610404
2.

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

Zecca C, Bovis F, Novi G, Capobianco M, Lanzillo R, Frau J, Repice AM, Hakiki B, Realmuto S, Bonavita S, Curti E, Brambilla L, Mataluni G, Cavalla P, Di Sapio A, Signoriello E, Barone S, Maniscalco GT, Maietta I, Maraffi I, Boffa G, Malucchi S, Nozzolillo A, Coghe G, Mechi C, Salemi G, Gallo A, Sacco R, Cellerino M, Malentacchi M, De Angelis M, Lorefice L, Magnani E, Prestipino E, Sperli F, Brescia Morra V, Fenu G, Barilaro A, Abbadessa G, Signori A, Granella F, Amato MP, Uccelli A, Gobbi C, Sormani MP.

Mult Scler. 2019 Oct 1:1352458519872889. doi: 10.1177/1352458519872889. [Epub ahead of print]

PMID:
31573386
3.

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.

Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Matarese G, Palladino R, Brescia Morra V.

Brain Sci. 2019 Sep 27;9(10). pii: E259. doi: 10.3390/brainsci9100259.

4.

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.

Moccia M, Tajani A, Acampora R, Signoriello E, Corbisiero G, Vercellone A, Sergianni P, Pennino F, Lanzillo R, Palladino R, Capacchione A, Brescia Morra V, Lus G, Triassi M.

PLoS One. 2019 Sep 19;14(9):e0222012. doi: 10.1371/journal.pone.0222012. eCollection 2019.

5.

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.

Solari A, Giovannetti AM, Giordano A, Tortorella C, Torri Clerici V, Brichetto G, Granella F, Lugaresi A, Patti F, Salvetti M, Pesci I, Pucci E, Centonze D, Danni MC, Bonavita S, Ferraro D, Gallo A, Gajofatto A, Nociti V, Grimaldi L, Grobberio M, Lanzillo R, Di Giovanni R, Gregori S, Manni A, Pietrolongo E, Bertagnoli S, Ronzoni M, Compagnucci L, Fantozzi R, Allegri B, Arena S, Buscarinu MC, Sabattini L, Quartuccio ME, Tsantes E, Confaloneri P, Tacchino A, Schiffmann I, Rahn AC, Kleiter I, Messmer Uccelli M, Barabasch A, Heesen C, The ManTra Project.

Front Neurol. 2019 Aug 22;10:916. doi: 10.3389/fneur.2019.00916. eCollection 2019.

6.

Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.

Colamatteo A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, Calì G, Bruzzese D, Maniscalco GT, Centonze D, Buttari F, Lanzillo R, Perna F, Zuccarelli B, Mottola M, Cassano S, Galgani M, Solito E, De Rosa V.

J Immunol. 2019 Oct 1;203(7):1753-1765. doi: 10.4049/jimmunol.1801683. Epub 2019 Aug 28.

PMID:
31462505
7.

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Clerico M, De Mercanti SF, Signori A, Iudicello M, Cordioli C, Signoriello E, Lus G, Bonavita S, Lavorgna L, Maniscalco GT, Curti E, Lorefice L, Cocco E, Nociti V, Mirabella M, Baroncini D, Mataluni G, Landi D, Petruzzo M, Lanzillo R, Gandoglia I, Laroni A, Frangiamore R, Sartori A, Cavalla P, Costantini G, Sormani MP, Capra R.

Neurotherapeutics. 2019 Aug 26. doi: 10.1007/s13311-019-00776-7. [Epub ahead of print]

PMID:
31452081
8.

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Calabrese M, Gasperini C, Tortorella C, Schiavi G, Frisullo G, Ragonese P, Fantozzi R, Prosperini L, Annovazzi P, Cordioli C, Di Filippo M, Ferraro D, Gajofatto A, Malucchi S, Lo Fermo S, De Luca G, Stromillo ML, Cocco E, Gallo A, Paolicelli D, Lanzillo R, Tomassini V, Pesci I, Rodegher ME, Solaro C; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.

9.

Correction to: Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Falco F, Moccia M, Chiodi A, Carotenuto A, D'Amelio A, Rosa L, Piscopo K, Falco A, Costabile T, Lauro F, Brescia Morra V, Lanzillo R.

Neurol Sci. 2019 May;40(5):1099-1100. doi: 10.1007/s10072-019-03880-w.

PMID:
30949781
10.

Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.

Criscuolo C, Cianflone A, Lanzillo R, Carrella D, Carissimo A, Napolitano F, de Cegli R, de Candia P, La Rocca C, Petrozziello T, Matarese G, Boscia F, Secondo A, Di Bernardo D, Brescia Morra V.

Sci Rep. 2019 Mar 12;9(1):4208. doi: 10.1038/s41598-018-38152-8.

11.

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.

Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Perna F, De Rosa A, Carotenuto A, Albero R, Matarese G, Palladino R, Brescia Morra V.

Ther Adv Neurol Disord. 2019 Feb 18;12:1756286418819074. doi: 10.1177/1756286418819074. eCollection 2019.

12.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Iannello A, Rolla S, Maglione A, Ferrero G, Bardina V, Inaudi I, De Mercanti S, Novelli F, D'Antuono L, Cardaropoli S, Todros T, Turrini MV, Cordioli C, Puorro G, Marsili A, Lanzillo R, Brescia Morra V, Cordero F, De Bortoli M, Durelli L, Visconti A, Cutrupi S, Clerico M.

Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.

13.

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.

Lavorgna L, Esposito S, Lanzillo R, Sparaco M, Ippolito D, Cocco E, Fenu G, Borriello G, De Mercanti S, Frau J, Capuano R, Trojsi F, Rosa L, Clerico M, Laroni A, Morra VB, Tedeschi G, Bonavita S.

J Neurol. 2019 Mar;266(3):707-716. doi: 10.1007/s00415-019-09193-4. Epub 2019 Jan 16.

PMID:
30649617
14.

Normative values of the Rao's Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education.

Falco F, Moccia M, Chiodi A, Carotenuto A, D'Amelio A, Rosa L, Piscopo K, Falco A, Costabile T, Lauro F, Brescia Morra V, Lanzillo R.

Neurol Sci. 2019 Apr;40(4):713-717. doi: 10.1007/s10072-019-3712-3. Epub 2019 Jan 15. Erratum in: Neurol Sci. 2019 Apr 5;:.

PMID:
30645750
15.

Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin.

Lanzillo R, Moccia M, Russo CV, Carotenuto A, Nozzolillo A, Petruzzo M, Palladino R, Chataway J, Brescia Morra V.

Mult Scler Relat Disord. 2019 Feb;28:193-196. doi: 10.1016/j.msard.2018.12.042. Epub 2019 Jan 2.

PMID:
30623857
16.

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.

Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A.

Neuroradiology. 2019 Feb;61(2):155-162. doi: 10.1007/s00234-018-02150-4. Epub 2019 Jan 8.

PMID:
30617409
17.

Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.

Pontillo G, Cocozza S, Lanzillo R, Russo C, Stasi MD, Paolella C, Vola EA, Criscuolo C, Borrelli P, Palma G, Tedeschi E, Morra VB, Elefante A, Brunetti A.

AJNR Am J Neuroradiol. 2019 Jan;40(1):99-106. doi: 10.3174/ajnr.A5915. Epub 2018 Dec 20.

PMID:
30573464
18.

Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.

Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M.

J Neurol. 2019 Feb;266(2):361-368. doi: 10.1007/s00415-018-9139-6. Epub 2018 Nov 29.

PMID:
30498912
19.

Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis.

Buonomo AR, Saccà F, Zappulo E, De Zottis F, Lanzillo R, Gentile I, Carotenuto A, Borgia G, Russo CV.

Mult Scler Relat Disord. 2019 Jan;27:44-45. doi: 10.1016/j.msard.2018.09.031. Epub 2018 Oct 2.

PMID:
30316174
20.

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.

Ugga L, Cocozza S, Pontillo G, Russo C, Brescia Morra V, Lanzillo R, Riccio E, Pisani A, Brunetti A.

Brain Behav. 2018 Nov;8(11):e01121. doi: 10.1002/brb3.1121. Epub 2018 Oct 2.

21.

Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.

Carotenuto A, Costabile T, Moccia M, Falco F, Scala MR, Russo CV, Saccà F, De Rosa A, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2019 Jan;27:1-6. doi: 10.1016/j.msard.2018.09.024. Epub 2018 Sep 22.

PMID:
30273697
22.

Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study.

Barbarulo AM, Lus G, Signoriello E, Trojano L, Grossi D, Esposito M, Costabile T, Lanzillo R, Saccà F, Morra VB, Conchiglia G.

Front Behav Neurosci. 2018 Sep 5;12:196. doi: 10.3389/fnbeh.2018.00196. eCollection 2018.

23.

e-Health and multiple sclerosis: An update.

Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S.

Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19. Review.

PMID:
30231004
24.

Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction.

Carotenuto A, Cocozza S, Quarantelli M, Arcara G, Lanzillo R, Brescia Morra V, Cerillo I, Tedeschi E, Orefice G, Bambini V, Brunetti A, Iodice R.

Brain Lang. 2018 Oct;185:47-53. doi: 10.1016/j.bandl.2018.08.003. Epub 2018 Aug 12.

PMID:
30110668
25.

Retinal vascular density in multiple sclerosis: a 1-year follow-up.

Lanzillo R, Cennamo G, Moccia M, Criscuolo C, Carotenuto A, Frattaruolo N, Sparnelli F, Melenzane A, Lamberti A, Servillo G, Tranfa F, De Crecchio G, Brescia Morra V.

Eur J Neurol. 2019 Jan;26(1):198-201. doi: 10.1111/ene.13770. Epub 2018 Sep 3.

PMID:
30102834
26.

Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis.

Lavorgna L, De Stefano M, Sparaco M, Moccia M, Abbadessa G, Montella P, Buonanno D, Esposito S, Clerico M, Cenci C, Trojsi F, Lanzillo R, Rosa L, Morra VB, Ippolito D, Maniscalco G, Bisecco A, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2018 Oct;25:175-178. doi: 10.1016/j.msard.2018.07.046. Epub 2018 Jul 31.

PMID:
30096683
27.

Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?

Cocozza S, Pontillo G, Russo C, Russo CV, Costabile T, Pepe A, Tedeschi E, Lanzillo R, Brescia Morra V, Brunetti A, Inglese M, Petracca M.

J Neurol. 2018 Oct;265(10):2260-2266. doi: 10.1007/s00415-018-8985-6. Epub 2018 Jul 28.

PMID:
30056570
28.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP.

Mult Scler. 2019 Aug;25(9):1263-1272. doi: 10.1177/1352458518790390. Epub 2018 Jul 25.

PMID:
30044207
29.

Clinical activity after fingolimod cessation: disease reactivation or rebound?

Frau J, Sormani MP, Signori A, Realmuto S, Baroncini D, Annovazzi P, Signoriello E, Maniscalco GT, La Gioia S, Cordioli C, Frigeni B, Rasia S, Fenu G, Grasso R, Sartori A, Lanzillo R, Stromillo ML, Rossi S, Forci B, Cocco E; i-MuST study group.

Eur J Neurol. 2018 Oct;25(10):1270-1275. doi: 10.1111/ene.13694. Epub 2018 Jul 10.

PMID:
29851435
30.

Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis.

Lanzillo R, Moccia M, Criscuolo C, Cennamo G.

Mult Scler. 2019 Feb;25(2):300-301. doi: 10.1177/1352458518768060. Epub 2018 Mar 28. No abstract available.

PMID:
29587576
31.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
32.

Online validation of the Italian version of the patient determined disease steps scale (PDDS) in people with multiple sclerosis.

Lavorgna L, Miele G, Petruzzo M, Lanzillo R, Bonavita S.

Mult Scler Relat Disord. 2018 Apr;21:108-109. doi: 10.1016/j.msard.2018.02.014. Epub 2018 Feb 12. No abstract available.

PMID:
29547779
33.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
34.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
35.

Cardiovascular profile improvement during Natalizumab treatment.

Moccia M, Albero R, Lanzillo R, Saccà F, De Rosa A, Russo CV, Carotenuto A, Palladino R, Brescia Morra V.

Metab Brain Dis. 2018 Jun;33(3):981-986. doi: 10.1007/s11011-017-0169-z. Epub 2017 Dec 18.

36.

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, Longobardi S, Visconti A, Matarese G.

Metabolism. 2017 Dec;77:39-46. doi: 10.1016/j.metabol.2017.08.011. Epub 2017 Sep 8.

37.

A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Saccà F, Russo CV, Lanzillo R, Brescia Morra V.

Mult Scler Relat Disord. 2018 Jan;19:50-54. doi: 10.1016/j.msard.2017.11.006. Epub 2017 Nov 6.

PMID:
29128737
38.

Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.

Laroni A, Signori A, Maniscalco GT, Lanzillo R, Russo CV, Binello E, Lo Fermo S, Repice A, Annovazzi P, Bonavita S, Clerico M, Baroncini D, Prosperini L, La Gioia S, Rossi S, Cocco E, Frau J, Torri Clerici V, Signoriello E, Sartori A, Zarbo IR, Rasia S, Cordioli C, Cerqua R, Di Sapio A, Lavorgna L, Pontecorvo S, Barrilà C, Saccà F, Frigeni B, Esposito S, Ippolito D, Gallo F, Sormani MP; iMUST group.

Neurology. 2017 Nov 28;89(22):2222-2229. doi: 10.1212/WNL.0000000000004686. Epub 2017 Nov 1.

PMID:
29093064
39.

Social Media and Multiple Sclerosis in the Posttruth Age.

Lavorgna L, Lanzillo R, Brescia Morra V, Abbadessa G, Tedeschi G, Bonavita S.

Interact J Med Res. 2017 Sep 27;6(2):e18. doi: 10.2196/ijmr.7879.

40.

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.

Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F, Cianflone A, Moccia M, Brescia Morra V.

Mult Scler. 2018 Nov;24(13):1706-1714. doi: 10.1177/1352458517729463. Epub 2017 Sep 21.

PMID:
28933233
41.

Cerebellar lobule atrophy and disability in progressive MS.

Cocozza S, Petracca M, Mormina E, Buyukturkoglu K, Podranski K, Heinig MM, Pontillo G, Russo C, Tedeschi E, Russo CV, Costabile T, Lanzillo R, Harel A, Klineova S, Miller A, Brunetti A, Morra VB, Lublin F, Inglese M.

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1065-1072. doi: 10.1136/jnnp-2017-316448. Epub 2017 Aug 26.

PMID:
28844067
42.

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.

Ghezzi A, Bianchi A, Baroncini D, Bertolotto A, Malucchi S, Bresciamorra V, Lanzillo R, Milani N, Martinelli V, Patti F, Chisari C, Rottoli M, Simone M, Paolicelli D, Visconti A; FUTURE Study Group.

Neurol Sci. 2017 Nov;38(11):1999-2005. doi: 10.1007/s10072-017-3091-6. Epub 2017 Aug 22.

PMID:
28831635
43.

Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.

Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De Rosa V, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G.

Clin Immunol. 2017 Oct;183:249-253. doi: 10.1016/j.clim.2017.08.011. Epub 2017 Aug 18.

PMID:
28823971
44.

Health-Related Coping and Social Interaction in People with Multiple Sclerosis Supported by a Social Network: Pilot Study With a New Methodological Approach.

Lavorgna L, Russo A, De Stefano M, Lanzillo R, Esposito S, Moshtari F, Rullani F, Piscopo K, Buonanno D, Brescia Morra V, Gallo A, Tedeschi G, Bonavita S.

Interact J Med Res. 2017 Jul 14;6(2):e10. doi: 10.2196/ijmr.7402.

45.

Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study.

Pontillo G, Cocozza S, Lanzillo R, Borrelli P, De Rosa A, Brescia Morra V, Tedeschi E, Palma G.

Front Neurol. 2017 Jun 19;8:294. doi: 10.3389/fneur.2017.00294. eCollection 2017.

46.

CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.

Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R.

J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12.

PMID:
28601287
47.

Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans.

Hayashi G, Jasoliya M, Sahdeo S, Saccà F, Pane C, Filla A, Marsili A, Puorro G, Lanzillo R, Brescia Morra V, Cortopassi G.

Hum Mol Genet. 2017 Aug 1;26(15):2864-2873. doi: 10.1093/hmg/ddx167.

48.

Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study.

Lavorgna L, Moccia M, Russo A, Palladino R, Riccio L, Lanzillo R, Brescia Morra V, Tedeschi G, Bonavita S.

Mult Scler Relat Disord. 2017 Apr;13:28-32. doi: 10.1016/j.msard.2017.02.001. Epub 2017 Feb 5.

49.

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Cocozza S, Olivo G, Riccio E, Russo C, Pontillo G, Ugga L, Migliaccio S, de Rosa D, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Tuttolomondo A, Caronia A, Russo CV, Lanzillo R, Brescia Morra V, Imbriaco M, Brunetti A, Tedeschi E, Pisani A.

Neuroradiology. 2017 Jun;59(6):563-570. doi: 10.1007/s00234-017-1829-8. Epub 2017 Apr 6.

PMID:
28386689
50.

What should we expect from multiple sclerosis therapy? Results of an integrated analysis of delayed-release dimethyl fumarate pivotal trials.

Lanzillo R.

Eur J Neurol. 2017 May;24(5):661-662. doi: 10.1111/ene.13283. Epub 2017 Mar 22. No abstract available.

PMID:
28332255

Supplemental Content

Loading ...
Support Center